Danaher - Masimo
Danaher Corporation (Danaher) proposes to acquire 100% of the outstanding share capital of Masimo Corporation (Masimo). Danaher is a global science and technology company. Danaher designs, manufactures and markets professional, medical, industrial and commercial products and services under three core segments: biotechnology, life sciences, and diagnostics. Masimo is a global medical technology company. Masimo is a provider of pulse oximetry and other patient sensors and monitoring solutions.
- Status
- Assessment completed
- ACCC determination
- Approved
- Stage
- Phase 1 - initial assessment
- Notified
- 2 April 2026
- Determination published
- 5 May 2026
Acquirers
- Danaher Corporation
Targets
- Masimo Corporation